-
1 Comment
Jayex Healthcare Limited is currently in a long term downtrend where the price is trading 31.5% below its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.3.
Jayex Healthcare Limited's total revenue sank by 35.7% to $2M since the same quarter in the previous year.
Its net income has dropped by 62.1% to $-694K since the same quarter in the previous year.
Finally, its free cash flow grew by 61.8% to $-608K since the same quarter in the previous year.
Based on the above factors, Jayex Healthcare Limited gets an overall score of 2/5.
| Exchange | AU |
|---|---|
| CurrencyCode | AUD |
| Sector | Healthcare |
| Industry | Health Information Services |
| ISIN | AU0000155293 |
| PE Ratio | None |
|---|---|
| Target Price | None |
| Market Cap | 6M |
| Beta | 1.3 |
| Dividend Yield | 0.0% |
Jayex Healthcare Limited develops healthcare industry service technologies and integrated dispensing automation systems for the pharmaceutical and healthcare sectors in Australia and the United Kingdom. The company offers Jayex Connect platform, a cloud-based patient engagement platform, which allow users for appointment booking, patient calling, patient check-in, health messaging, and script management. Jayex Healthcare Limited was founded in 2006 and is based in Milton, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for JHL.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
